# Alternative Dosing And Prevention of Transfusions (ADAPT)

> **NCT05662098** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 100 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT05662098
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-16
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05662098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05662098, "Alternative Dosing And Prevention of Transfusions (ADAPT)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05662098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*